A potential diagnostic marker for ovarian cancer: Involvement of the histone acetyltransferase, human males absent on the first

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 393-400

  Liu, Ning ^a   Zhang, Rui ^b   Zhao, Xiaoming ^b   Su, Jiaming ^b   Bian, Xiaolei ^a   Ni, Jinsong ^a   Yue, Ying ^a   Cai, Yong ^b   Jin, Jingji ^b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Histone acetyltransferase; Human males absent on the first; Ovarian cancer

Indexed keywords

CARBONATE DEHYDRATASE IX; CD45 ANTIGEN; HISTONE ACETYLTRANSFERASE; HUMAN MALES ABSENT ON THE FIRST; HYPOCALCIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE SILENCING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84879482056     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1380     Document Type: Article

References (25)

1. Hilfiker A, Hilfiker-Kleiner D, Pannuti A, Lucchesi JC: mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila. EMBO J 16: 2054-2060, 1997.
2. Smith ER, Cayrou C, Huang R, Lane WS, Côtê J and LucchesiJC: A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol Cell Biol 25: 9175-9188, 2005.
3. Mendjan S, Taipale M, Kind J, Holz H, Gebhardt P, SchelderM, Vermeulen M, Buscaino A, Duncan K, Mueller J, Wilm M, Stunnenberg HG, Saumweber H and Akhtar A: Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila. Mol Cell 21: 811-823, 2006.
4. Cai Y, Jin J, Swanson SK, Cole MD, Choi SH, Florens L, Washburn MP, Conaway JW and Conaway RC: Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex. J Biol Chem 285: 4268-4272, 2010.
5. Carrozza MJ, Utley RT, Workman JL and Côté J: The diverse functions of histone acetyltransferase complexes. Trends Genet19: 321-329, 2003.
6. Gupta A, Guerin-Peyrou TG, Sharma GG, Park C, Agarwal M, Ganju RK, Pandita S, Choi K, Sukumar S, Pandita RK, Ludwig T and Pandita TK: The mammalian ortholog of Drosophla MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis. Mol Cell Biol 28: 397-409, 2008.
7. Sharma GG, So S, Gupta A, Kumar R, Cayrou C, AvvakumovN, Bhadra U, Pandita RK, Porteus MH, Chen DJ, Cote J and PanditaTK: MOF and histone H4 acetylation at lysine 16 are critical for DNA damage response and double-strand break repair. Mol Cell Biol 30: 3582-3595, 2010.
8. Rea S, Xouri G and Akhtar A: Males absent on the first (MOF): from flies to humans. Oncogene 26: 5385-5394, 2007.
9. Taipale M, Rea S, Richter K, Vilar A, Lichter P, Imhof A and Akhtar A: hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Mol Cell Biol 25: 6798-6810, 2005.
10. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
11. Schwab LP, Peacock DL, Majumdar D, Ingels JF, Jensen LC, Smish KD, Cushing RC and Seagroves TN: Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Breast Cancer Res 14: R6, 2012.
12. McDonald PC, Winum JY, Supuran CT and Dedhar S: Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget 3: 84-97, 2012.
13. Law AY and Wong CK: Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. Exp Cell Res 316: 466-476, 2010.
14. Choschzick M, Oosterwijk E, Müller V, Woelber L, SimonR, Moch H and Tennstedt P: Overexpression of carbonic anhydraseIX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer. Virchows Arch 459: 193-200, 2011.
15. Seeber LM, Horrée N, Vooijs MA, Heintz AP, van der Wall E, Verheijen RH and van Diest PJ: The role of hypoxia inducible factor-1alpha in gynecological cancer. Crit Rev Oncol Hematol78: 173-184, 2011.
16. Elsheikh SE, Green AR, Rakha EA, Powe DG, Ahmed RA, Collins HM, Soria D, Garibaldi JM, Paish CE, Ammar AA, Grainge MJ, Ball GR, Abdelghany MK, Martinez-Pomares L, Heery DM and Ellis IO: Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 69: 3802-3809, 2009.
17. Pfister S, Rea S, Taipale M, Mendrzyk F, Straub B, Ittrich C, Thuerigen O, Sinn HP, Akhtar A and Lichter P: The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. Int J Cancer122: 1207-1213, 2008.
18. Kulski JK and Dawkins RL: The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics 49: 404-412, 1999.
19. Salih HR and Nüssler V: Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance? Eur J Med Res 6: 323-332, 2001.
20. Kübler K, Arndt PF, Wardelmann E, Landwehr C, Krebs D, Kuhn W and van der Ven K: Genetic alterations of HLA-class II in ovarian cancer. Int J Cancer 123: 1350-1356, 2008.
21. Wang Y, Zhang R, Wu D, Lu Z, Sun W, Cai Y, Wang C and JinJ: Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma. J Exp Clin Cancer Res 32: 8, 2013.
22. Seeber LM and van Diest PJ: Epigenetics in ovarian cancer. Methods Mol Biol 863: 253-269, 2012.
23. Asadollahi R, Hyde CA and Zhong XY: Epigenetics of ovarian cancer: from the lab to the clinic. Gynecol Oncol 118: 81-87, 2010.
24. Balch C, Matei DE, Huang TH and Nephew KP: Role of epigenomics in ovarian and endometrial cancers. Epigenomics 2: 419-447, 2010.
25. Song JS, Chun SM, Lee JY, Kim DK, Kim YH and Jang SJ: The histone acetyltransferase hMOF is overexpressed in non-small cell lung carcinoma. Korean J Pathol 45: 386-396, 2011.